Journal ArticleDOI
Endometrial morphology in asymptomatic postmenopausal women
David F. Archer,Kathleen McIntyre-Seltman,Walter W. Wilborn,Edmond A. Dowling,Frederick Cone,George W. Creasy,Michael E. Kafrissen +6 more
Reads0
Chats0
TLDR
It is concluded that the yield for neoplasia is so low that screening endometrial biopsy is not justified in asymptomatic perimenopausal and postmenopausal women.About:
This article is published in American Journal of Obstetrics and Gynecology.The article was published on 1991-08-01. It has received 142 citations till now. The article focuses on the topics: Endometrial biopsy & Endometrial cancer.read more
Citations
More filters
Journal ArticleDOI
Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities
Rebecca Smith-Bindman,Karla Kerlikowske,Vickie A. Feldstein,Leslee L. Subak,Juergen Scheidler,Mark R. Segal,Richard J. Brand,Deborah Grady +7 more
TL;DR: Endovaginal ultrasound has a high sensitivity for detecting endometrial cancer and otherendometrial disease and can reliably identify postmenopausal women with vaginal bleeding who are highly unlikely to have significant endometrian disease so that endometri sampling may be unnecessary.
Journal ArticleDOI
How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding.
TL;DR: The aim of this study was to determine an endometrial thickness threshold that should prompt biopsy in a postmenopausal woman without vaginal bleeding.
Journal ArticleDOI
Transvaginal Ultrasonography Compared with Endometrial Biopsy for the Detection of Endometrial Disease
Robert Langer,June J Pierce,Katherine A. O'Hanlan,Susan R. Johnson,Mark A. Espeland,Jose Trabal,Vanessa M. Barnabei,Maria J. Merino,Robert E. Scully +8 more
TL;DR: Transvaginal ultrasonography has a poor positive predictive value but a high negative predictive value for detecting serious endometrial disease in asymptomatic postmenopausal women.
Journal ArticleDOI
Low-Dose Esterified Estrogen Therapy: Effects on Bone, Plasma Estradiol Concentrations, Endometrium, and Lipid Levels
Harry K. Genant,J. Lucas,Stuart R. Weiss,Mark Akin,Ronald D. Emkey,Heidi McNaney-Flint,Robert W. Downs,Joseph Mortola,Nelson B. Watts,Hwa Ming Yang,Niranyan Banav,John J. Brennan,Joseph C. Nolan +12 more
TL;DR: Esterified estrogens at doses from 0.3 to 1.25 mg/d, administered unopposed by progestin, produce a continuum of positive changes on bone and lipids and plasma estradiol concentrations increased with esterified estrogen dose and were related to positive bone mineral densities.
Journal ArticleDOI
Endometrial assessment re-visited.
C. P. Spencer,M. I. Whitehead +1 more
TL;DR: A literature search using the MEDLINE database was performed using the MeSH headings: transvaginal ultrasound, hysteroscopy, endometrial biopsy and endornetrial cytology, and a total of 142 citations were found using these methods.
References
More filters
Journal Article
The need for extended treatment of anaphylaxis
Journal ArticleDOI
Diagnostic dilation and curettage: a reappraisal.
TL;DR: Until the alleged benefits of diagnostic D & C can be shown to outweigh its risks and costs, it probably should not be the primary procedure used for obtaining most samples of endometrium.
Journal Article
Use of the progestogen challenge test to reduce the risk of endometrial cancer.
TL;DR: The progestogen challenge test has been devised to identify post menopausal women at greatest risk for adenocarcinoma of the endometrium and it is concluded that the use of this test will reduce the risk of endometrial cancer in both estrogen-treated postmenopausal women and women with increased endogenous estrogens.
Journal Article
Detection of endometrial carcinoma and hyperplasia in asymptomatic women.
TL;DR: It is strongly suggested that in asymptomatic women past the age of 50, endometrial hyperplasia does not necessarily precede or accompany the development of endometricrial carcinoma.
Related Papers (5)
Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
Howard L. Judd,Irma Mebane-Sims,Claudine Legault,Carol Wasilauskas,Susan Johnson,Maria J. Merino,Elizabeth Barrett-Connor,Jose Trabal,Valery T. Miller,Vanessa M. Barnabei,Ginny Levin,Trudy L. Bush,David C. Foster,Howard A. Zacur,J. Donald Woodruff,Marcia L. Stefanick,Peter D. Wood,Allison Akana,W. Leroy Heinrichs,Katherine A. O'Hanlan,Richard P. Buyalos,Gail A. Greendale,Kathy Lozano,Mary Lou Carrion-Petersen,Carmella Cavero,Robert Langer,Helmut G. Schrott,Jo Ann Benda,Charles deProsse,Deborah Fedderson,Susan R. Johnson,Carl J. Pauerstein,Mohammad M. Ahmad,Herbert P. Brown,Robert S. Schenken,Mercedes Rodriguez-Sifuentes,Philip T. Valente,Mark A. Espeland,H.Bradley Wells,Kathy Lane,Irma L. Mebane-Sims,Joseph Kelaghan,Joan McGowan,Judith E. Fradkin,Sheryl S. Sherman,Robert E. Scully +45 more